New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 29, 2014
11:46 EDTINO, SKX, DECK, QLIK, TTS, INFN, MLNX, ANGI, PBYI, CRUSOptions with decreasing implied volatility
Options with decreasing implied volatility: INO PBYI ANGI MLNX INFN TTS QLIK DECK SKX CRUS
News For INO;PBYI;ANGI;MLNX;INFN;TTS;QLIK;DECK;SKX;CRUS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
October 22, 2014
17:29 EDTINFNInfinera sees Q4 EPS 11c plus or minus a couple of cents, consensus 5c
Subscribe for More Information
17:08 EDTMLNXMellanox sees Q4 revenue $133M-$137M, consensus $129.31M
Sees Q4 Non-GAAP gross margins of 69%-70%. An increase in non-GAAP operating expenses of 4%-6%.
17:06 EDTMLNXMellanox reports Q3 adjusted EPS 38c, consensus 26c
Subscribe for More Information
16:30 EDTSKXSkechers sees momentum carrying into 2015
The company said, "The continuous record revenue quarters in 2014 and the strong growth in all of our key business segments is evidence of the relevancy and demand for Skechers footwear worldwide. The more than 50 percent increase in our backlogs at the end of September and the strong sales during the first few weeks of October give us confidence that the momentum we are experiencing now will continue for the remainder of the year and into 2015. We are continuing our retail expansion and plan to open an additional 10 to 15 Company-owned Skechers stores before the end of the year, in addition to the 22 that opened in the third quarter and the five that have already opened this month. We also plan to open another 35 to 45 Skechers stores through our international distributor and franchise partners before the end of the year—which will bring us to the 1,000 store milestone. We are also improving our international efficiencies with the opening of a new distribution facility in Chile in the third quarter and the completion of phase one of the automation of our European Distribution Center in Belgium in the fourth quarter. With our relevant product and advertising, market share gain, and solid financial position, including, $440.8 million in cash, the Company is well positioned for continued growth. Though the fourth quarter is historically our smallest sales quarter for our international division, we remain comfortable with the analysts’ current consensus for both revenue and earnings. Given the strength of our backlogs for the first quarter of 2015, we anticipate top-line growth to be 15 to 20 percent.”
16:19 EDTINFNInfinera reports Q3 EPS 11c, consensus 7c
Subscribe for More Information
16:07 EDTSKXSkechers reports Q3 EPS $1.00, consensus 93c
Subscribe for More Information
14:11 EDTANGIAngie's List valuation attractive with today's sell-off, says Barrington
Barrington lowered its price target for Angie's List shares to $10 from $15 following the company's Q3 results but says the stock is attractively valued with today's pullback. The firm notes Angie's management neither confirmed nor denied the rumor that it's shopping itself to a buyer. Barrington sees private equity as a more likely near]term buyer than strategic alternatives. It keeps an Outperform rating on the stock.
09:21 EDTANGIOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Dow Chemical (DOW), up 3.7%... iRobot (IRBT), up 12%... Six Flags (SIX), up 13%... GlaxoSmithKline (GSK), up 2%... Broadcom (BRCM), up 7%... Boston Scientific (BSX), up 4.3%... Abbott (ABT), up 1.8%... Yahoo! (YHOO), up 6%. ALSO HIGHER: Blue Earth (BBLU), up 26.4% after CEO says statements in Seeking Alpha blog are "false and misleading."... GW Pharmaceuticals (GWPH), up 5.4% after Epidiolex receives orphan designation from EMA. DOWN AFTER EARNINGS: 3D Systems (DDD), down 15%... Biogen (BIIB), down 7%... Lumber Liquidators (LL), down 13.4%... Norfolk Southern (NSC), down 3%... Angie's List (ANGI), down 8.8%. ALSO LOWER: Nanosphere (NSPH), down 33% after filing secondary, reporting preliminary Q3 revenue... Himax Technologies (HIMX), down 16% after announcing that Google (GOOG) will not exercise an additional investment option in the company... Cree (CREE), down 10.5%, downgraded at DA Davidson and Canaccord following the company's Q1 earnings results... Ocwen Financial (OCN), down 7% after downgraded to Hold at Evercore, downgraded to Neutral at BofA Merrill Lynch... VMware (VMW), down 7.8%, downgraded at Nomura and Raymond James following the company's Q3 results.
07:08 EDTANGIAngie's List reports Q3 memberships added 350.38K vs. 371.32K last year
Angie's List reports Q3 gross paid memberships added down 6% versus last year. Total paid memberships were 2.98M at the end of Q3 compared to 2.38M last year. Marketing cost per paid membership acquisition was $64 in Q3 versus $76 last year.
07:03 EDTANGIAngie's List sees Q4 revenue $80M-$82M, consensus $84.15M
Subscribe for More Information
07:02 EDTANGIAngie's List reports Q3 EPS (9c), consensus (6c)
Subscribe for More Information
06:25 EDTDECKDeckers Outdoor risk/reward favorable into results, says Jefferies
Subscribe for More Information
October 21, 2014
14:04 EDTCRUSEarnings Preview: Analysts divided on Broadcom ahead of Q3 report
Subscribe for More Information
07:15 EDTPBYIFDA to hold workshop on breast cancer drug development
Subscribe for More Information
06:10 EDTINOInovio, MedImmune, UPENN awarded $12.2M collaborative study by DARPA
Inovio Pharmaceuticals (INO) announced the Defense Advanced Research Projects Agency, or DARPA, has awarded $12.2M for a collaborative study that will be conducted by scientists from the Perelman School of Medicine at the University of Pennsylvania; Inovio Pharmaceuticals; and MedImmune, the global biologics research and development arm of AstraZeneca (AZN). The group will develop DNA-based monoclonal antibodies, or mAbs, for infectious disease treatment. DARPA is an agency of the US Department of Defense that creates and supports novel technologies important for national security. Together, the three organizations will develop and assess the DNA mAbs in preclinical studies using technology developed by Penn and licensed by Inovio. The collaboration will focus on three disease areas – influenza virus, Pseudomonas aeruginosa and Staphylococcus aureus.
October 20, 2014
18:51 EDTCRUSOn The Fly: After Hours Movers
Subscribe for More Information
18:22 EDTCRUSSkyworks Solutions, Cirrus Logic, others higher after Apple reports Q4 results
The following stocks are moving higher in the after hours following Apple's Q4 results: ARM Holdings (ARMH) is up 1.1%, Skyworks Solutions (SWKS) is higher by 2.2% ,NXP Semiconductors (NXPI), up 2.28%,Cirrus Logic (CRUS) is up 2%, RF Micro Devices (RFMD) gains 1.53% and Avago Technologies (AVGO) is up 1.17%.
09:36 EDTINFNActive equity options trading on open
Subscribe for More Information
07:16 EDTANGIAmerican Academy of Ophthalmology to hold annual meeting
AAO Annual Meeting 2014 is being held in Chicago on October 18-21.
October 17, 2014
09:42 EDTMLNXMellanox to host analyst day
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use